Scienture (SCNX) Competitors $0.94 +0.01 (+1.18%) As of 01:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock SCNX vs. PTLE, RAVE, GDC, BANL, LTCH, CGTL, DTCK, SAG, TAIT, and HYFMShould you be buying Scienture stock or one of its competitors? The main competitors of Scienture include PTL (PTLE), Rave Restaurant Group (RAVE), GD Culture Group (GDC), CBL International (BANL), Latch (LTCH), Creative Global Technology (CGTL), Davis Commodities (DTCK), SAG (SAG), Taitron Components (TAIT), and Hydrofarm Holdings Group (HYFM). These companies are all part of the "wholesale" industry. Scienture vs. PTL Rave Restaurant Group GD Culture Group CBL International Latch Creative Global Technology Davis Commodities SAG Taitron Components Hydrofarm Holdings Group Scienture (NASDAQ:SCNX) and PTL (NASDAQ:PTLE) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk, institutional ownership and community ranking. Which has stronger valuation & earnings, SCNX or PTLE? PTL has higher revenue and earnings than Scienture. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScienture$136.64K86.19-$17.84MN/AN/APTL$108.13M0.41N/AN/AN/A Is SCNX or PTLE more profitable? PTL's return on equity of 0.00% beat Scienture's return on equity.Company Net Margins Return on Equity Return on Assets ScientureN/A -77.60% -62.29% PTL N/A N/A N/A Does the media refer more to SCNX or PTLE? In the previous week, PTL had 1 more articles in the media than Scienture. MarketBeat recorded 3 mentions for PTL and 2 mentions for Scienture. PTL's average media sentiment score of 1.49 beat Scienture's score of 0.94 indicating that PTL is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Scienture 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PTL 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor SCNX or PTLE? Scienture and PTL both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformScientureN/AN/APTLN/AN/A Do institutionals & insiders believe in SCNX or PTLE? 5.7% of Scienture shares are owned by institutional investors. 49.7% of Scienture shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryPTL beats Scienture on 5 of the 8 factors compared between the two stocks. Get Scienture News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCNX vs. The Competition Export to ExcelMetricScienturePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.78M$6.72B$5.49B$7.94BDividend YieldN/A3.05%5.11%4.23%P/E RatioN/A7.3722.5818.55Price / Sales86.19242.94397.25103.00Price / CashN/A65.8538.1834.62Price / Book2.096.486.704.26Net Income-$17.84M$143.68M$3.23B$248.39M7 Day Performance-0.94%1.79%1.26%1.27%1 Month Performance-29.78%6.68%3.75%3.85%1 Year PerformanceN/A-2.73%15.78%5.23% Scienture Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCNXScientureN/A$0.94+1.2%N/AN/A$11.78M$136,643.000.00N/AGap DownPTLEPTLN/A$1.12-17.4%N/AN/A$42.14M$108.13M0.00N/AGap UpRAVERave Restaurant Group2.0153 of 5 stars$2.41-2.2%N/A+20.0%$35.38M$12.24M13.3620Analyst ForecastGDCGD Culture Group1.014 of 5 stars$2.48+1.2%N/A+260.6%$30.46M$-150,000.00-1.6460BANLCBL International0.9043 of 5 stars$0.97-3.6%N/A-3.0%$26.79M$592.52M0.0035Short Interest ↓Gap DownLTCHLatchN/A$0.14flatN/A-72.0%$23.08M$48.39M0.00420CGTLCreative Global TechnologyN/A$1.05-11.4%N/AN/A$22.40M$35.61M0.00N/AHigh Trading VolumeDTCKDavis Commodities0.9802 of 5 stars$0.68+1.8%N/A-41.1%$16.37M$159.84M0.0022Short Interest ↓News CoverageGap DownSAGSAGN/A$1.44+42.6%N/AN/A$14.22M$56.39M0.00N/AHigh Trading VolumeTAITTaitron Components2.2272 of 5 stars$2.20+0.2%N/A-31.4%$13.22M$4.14M9.5410Short Interest ↑HYFMHydrofarm Holdings Group3.1906 of 5 stars$2.55+3.0%$7.00+175.0%-73.2%$11.83M$190.29M-0.18840Short Interest ↑Gap Up Related Companies and Tools Related Companies PTLE Competitors RAVE Competitors GDC Competitors BANL Competitors LTCH Competitors CGTL Competitors DTCK Competitors SAG Competitors TAIT Competitors HYFM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCNX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scienture Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scienture With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SCNX Stock Free SCNX Stock Alerts